Skip to main content

Finished Projects

Finished Projects

Catalan financed projects

Spin-off creation to bring an advanced therapy for Fabry disease to clinical phase

Innova4Fabry

Reference: 2021 INNOV 00053
Funding entity: AGAUR, Generalitat de Catalunya
Duration: 16/11/2022-15/05/2024
Beneficiaries: Nanomol-bio (ICMAB-CSIC)
Coordination: Nora Ventosa (ICMAB-CSIC)
Total money awarded: 84.000,06 €

RNA-based nanomedicine for cancer therapy

Reference: 2021 PROD 00059
Funding entity:
 AGAUR, Generalitat de Catalunya
Duration: 20/10/2022-19/04/2024
Beneficiaries: Vall d’Hebron Research Institute (VHIR) and Nanomol-bio (ICMAB-CSIC).
Coordination: Miguel F. Segura (VHIR, Spain)
Total money awarded: 100.000 €
Nanomol-bio coordinator: Nora Ventosa and Mariana Köber (ICMAB-CSIC)
Total money awarded to Nanomol-bio: 17.062,50 €

Engineering Novel Nanodelivery Systems Against Antimicrobioal Resistance

Nano-Resist

Reference: TECSPR19-1-0065
Funfing entity:
EU-ACCIO TECNIO Spring Industry, Generalitat de Catalunya
Duration: 01/05/2021 – 31/04/2023 
Beneficiaries:
Nanomol-bio (ICMAB-CSIC), Tecnológico de Monterrey, Universitat Autònoma de Barcelona, Institut de Recerca i Tecnologies Agroalimentàries, Nanomol Technologies, and i-Vascular.
Coordination: Karla P. Mayolo and Imma Ratera (ICMAB-CSIC)
Total money awarded:
135.240 €

Preclinical and clinical studies applied nanovesicles (quatsomes) with EGF chronic venous ulcers

Nanonafres

Reference:COMRDI15-1-0023-03
Funding entity:
Ris3Cat, Generalitat de Catalunya, and FEDER-EU cofunded
Duration: 15/10/2016-14/10/2019
Beneficiaries: Nanomol Technologies, Nanomol-bio (ICMAB-CSIC), BIOMED-LEITAT, EAP Osona Sur-Alt Congost SLP, EAP Vallcarca-Sant Gervasi, Consorci Sanitari de Terrassa, the Fundació Salut-Consorci Sanitari del Maresme, and the Centro de Ingeniería Genética y Biotecnología.
Coordination: Santi Sala (Nanomol Technologies, Spain)
Total money awarded: 2.300.000 €
Nanomol-bio coordinator: Nora Ventosa (ICMAB-CSIC)
Total money awarded to Nanomol-bio: 99.584,69€ €

Spanish financed projects

New nanoparticles for image guided surgery

NANOIMOC

Reference: PDC2021-121481-I00
Funding entity: AEI, Gobierno de España
Duration: 01/12/2021-31/08/2024
Beneficiaries: Nanomol-bio (ICMAB-CSIC), Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, and Universidad de Cantabria.
Coordination: Nora Ventosa (ICMAB-CSIC)
Total money awarded: 149.500 €

Radical Dendrimers as New Metal-free MRI Contrast Agents for Glioblastoma Diagnosis

Radical-NEED

Reference: BBN23PIV01
Funding entity:
 CIBER-BBN
Duration: 01/05/2023-31/07/2024
Beneficiaries: Nanomol-bio (CIBER-BBN) and Institut de Biotecnologia i Biomedicina.
Coordination: Vega Lloveras (CIBER-BBN)
Total money awarded: 20.000 €

Ayudas extraordinarias para la preparación de proyectos 2023

Reference: PID2022-137332OB-I00
Funding entity: CSIC
Duration: 01/06/2023-03/01/2024
Beneficiaries: Nanomol-bio (ICMAB-CSIC)
Coordination: Nora Ventosa and Imma Ratera (ICMAB-CSIC)
Total money awarded: 27.500 €

Procesamiento de moléculas para crear materiales híbridos estructurados jerárquicamente para aplicaciones biomédicas

Mol4Bio

Reference: PID2019-105622RB-I00
Funding entity: AEI, Gobierno de España
Duration: 01/06/2020-31/12/2023
Beneficiaries: Nanomol-bio (ICMAB-CSIC)
Coordination: Nora Ventosa and Imma Ratera (ICMAB-CSIC)
Total money awarded: 266.200 €

Application of the SMARTY Nanovesicle Platform to Treat Congenital Muscular Dystrophy

Dystro-Smarty

Funfing entity: Ministerio de Economya y Competividad, Gobierno de España
Duration: 01/06/2022-31/12/2023
Beneficiaries:
Nanomol-bio (ICMAB-CSIC).
Coordination: Mariana Köber and Nora Ventosa (ICMAB-CSIC)
Total money awarded:
60.000 €

In vivo Studies of Radical Dendrimers as Contrast Agents for Magnetic Resonance Imaging

Viraden

Funfing entity: Ministerio de Ciencia e Innovación, Gobierno de España
Duration: 01/09/2021-31/08/2023
Beneficiaries:
Nanomol-bio (ICMAB-CSIC).
Coordination: Pepe Vidal Gancedo (ICMAB-CSIC)
Total money awarded:
70.000 €

Targeted Quatsome nanocarriers for the delivery of microRNA for neuroblastoma therapy

Tag-Smartly

Reference: BBN20PIV01
Funfing entity:
CIBER-BBN
Duration: 01/01/2021-31/12/2022
Beneficiaries:
Nanomol-bio (CIBER-BBN), Institut de Química Acançada de Catalunya (CIBER-BBN), Vall d’Hebron Institut de Recerca, and Nanomol-Technologies.
Coordination: Nora Ventosa and Mariana Köber (Nanomol-bio, CIBER-BBN)
Total money awarded:
45.000 €

European financed projects

Smart multifunctional GLA-nanoformulation for Fabry disease

Smart4Fabry

Reference: 720942
Funfing entity:
European Union
Duration: 01/01/2017-31/12/2020
Beneficiaries:
Nanomol-bio (CIBER-BBN), Vall d’Hebron Institut de Recerca (CIBER-BBN), Parc Científic de Barcelona (CIBER-BBN), Institut de Biotecnologia i Biomedicina (CIBER-BBN), Aarhus Universitet, Technion, Johanneum Research, Leanbio, Nanomol Technologies, Praxis Pharmaceutical, Covance, Drug Development and Regulation, and BioNanoNet Forschungsgesellschaft.
Coordination:
Nora Ventosa (Nanomol-bio, CIBER-BBN)
Total money awarded:
5.845258,63 €
Total money awarded to Nanomol-bio:
98.418,05 €
Webpage